News
Company Announcement for Zelnite®
2024/7/17 TaiRx, Inc. hereby declares that Zelnite® [...]
TaiRx‘s injectable product, Zelnite®, has been approved by TFDA to add high dosage and change drug labeling
2024/5/9 In 2018, TaiRx received approval from [...]
Mr. Andrew Lin’s appointment as Chairman of TaiRx, Inc. is effective as of December 9, 2020.
2020/12/9 Andrew Lin [...]
TaiRx’s anti-cancer drug CVM-1118 won the renewal of Excelsior Award in 2020.
2020/12/1 Having been [...]